title: ESF-EMBO Symposium "Molecular Biology and Innovative Therapies in Sarcomas of Childhood and Adolescence" Sept 29-Oct 4, Polonia Castle Pultusk, Poland.
abstract: Rhabdomyosarcoma (RMS) and Ewing sarcoma (ES) are among the most common pediatric sarcomas (Arndt et al., 2012). Despite sarcomas representing a highly heterogeneous group of tumors, ES and alveolar RMS (ARMS) typically share one common genetic characteristic, namely a specific chromosomal translocation (Helman and Meltzer, 2003; Lessnick and Ladanyi, 2012). These translocations generate fusion proteins, which are composed of two transcription factors (TF). Typically, one TF is a developmentally regulated factor that is essential for proper specification of a given lineage and provides the DNA-binding domain, while the partner TF contributes a transactivation domain that drives aberrant expression of target genes. Based on these common genetic characteristics, the first ESF-EMBO research conference entitled "Molecular Biology and Innovative Therapies in Sarcomas of Childhood and Adolescence" with special focus on RMS and ES was held at the Polonia Castle in Pultusk, Poland. The conference gathered 70 participants from more than 15 countries and several continents representing most research groups that are active in this field.
authors.affiliation: Department of Oncology and Children's Research Center, University Children's Hospital Zurich , Zurich , Switzerland.
authors.forename: Beat W
authors.initials: BW
authors.lastname: Schäfer
authors.forename: Ewa
authors.initials: E
authors.lastname: Koscielniak
authors.forename: Heinrich
authors.initials: H
authors.lastname: Kovar
authors.forename: Simone
authors.initials: S
authors.lastname: Fulda
keywords: EWS/Fli1; Ewing sarcoma; PAX3/FOXO1; Rhabdomyosarcoma; therapeutics